Reunion Neuroscience Inc Quick Ratio (REUN) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Reunion Neuroscience Inc   (NASDAQ: REUN)

Reunion Neuroscience Inc 's Quick Ratio

REUN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2023, Quick Ratio deteriorated to 3.22 a new company low.

Within Medical Equipment & Supplies industry 66 other companies have achieved higher Quick Ratio than Reunion Neuroscience Inc in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 999 to 1142.

Explain Quick Ratio?
How much Cash & cash equivalents REUN´s has?
What are REUN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

REUN Quick Ratio (Mar 31 2023)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Mar 31 2022)
Y / Y Current Liabilities Change 25810.44 % 35085.21 % - - -
Y / Y Cash & cash equivalent Change -59.19 % -31.91 % - - -
Quick Ratio MRQ 3.22 3.22 3.22 3.22 2044.76
REUN's Total Ranking # 1142 # 999 # 1142 # 0 #
Seq. Current Liabilities Change 0 % 0 % 0 % 25810.44 % 35.8 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -59.19 % 66.82 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 67
Healthcare Sector # 552
Overall Market # 1142


Quick Ratio Statistics
High Average Low
3.22 3.22 3.22
(Mar 31 2023)  




Financial Statements
Reunion Neuroscience Inc 's Current Liabilities $ 6 Millions Visit REUN's Balance sheet
Reunion Neuroscience Inc 's Cash & cash equivalent $ 21 Millions Visit REUN's Balance sheet
Source of REUN's Sales Visit REUN's Sales by Geography


Cumulative Reunion Neuroscience Inc 's Quick Ratio

REUN's Quick Ratio for the trailling 12 Months

REUN Quick Ratio

 (Mar 31 2023)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 59587.67 % 105591.41 % - - -
Y / Y Cash & cash equivalent TTM Growth 2.07 % 271.08 % - - -
Quick Ratio TTM 3.22 5.84 9.5 15.74 1883.49
Total Ranking TTM # 4267 # 0 # 0 # 0 #
Seq. Current Liabilities TTM Growth 33.16 % 49.69 % 99.33 % 14921.92 % 135.8 %
Seq. Cash & cash equivalent TTM Growth -26.61 % -7.92 % 20.33 % 25.52 % 166.82 %

Quick ratio ranking by company, industry and sector >> Back to REUN Financial Strength Comparisons >> Go to Compare REUN Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2023 to $6.47 millions, cumulative Quick Ratio decreased to 3.22 below the Reunion Neuroscience Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 238 other companies have achieved higher Quick Ratio than Reunion Neuroscience Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 0 to 4267.

Explain Quick Ratio?
How much Cash & cash equivalents REUN´s has?
What are REUN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 239
Healthcare Sector # 1138
Within the Market # 4267


trailing twelve months Quick Ratio Statistics
High Average Low
3.22 3.22 3.22
(Mar 31 2023)  




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Alpha Pro Tech Ltd   8.26 $ 13.821  Millions$ 1.673  Millions
Beyond Air Inc   8.26 $ 45.882  Millions$ 5.557  Millions
Sonendo Inc   8.24 $ 74.947  Millions$ 9.098  Millions
Skinhealth Systems Inc   7.90 $ 532.282  Millions$ 67.420  Millions
Logicmark Inc  7.69 $ 9.782  Millions$ 1.272  Millions
Treace Medical Concepts Inc   7.33 $ 170.662  Millions$ 23.296  Millions
Transmedics Group Inc   6.82 $ 195.375  Millions$ 28.635  Millions
Inari Medical Inc   6.79 $ 328.446  Millions$ 48.340  Millions
Lyra Therapeutics Inc   6.54 $ 82.707  Millions$ 12.644  Millions
Vivani Medical Inc   6.49 $ 38.073  Millions$ 5.863  Millions
Avita Medical Inc   6.41 $ 73.571  Millions$ 11.486  Millions
Solana Company  6.34 $ 11.340  Millions$ 1.789  Millions
Iradimed Corporation  6.33 $ 42.777  Millions$ 6.756  Millions
Modular Medical Inc  6.25 $ 3.899  Millions$ 0.624  Millions
Sharps Technology Inc   5.84 $ 5.541  Millions$ 0.949  Millions
Semler Scientific inc   5.63 $ 42.968  Millions$ 7.632  Millions
Outset Medical Inc   5.63 $ 249.213  Millions$ 44.268  Millions
Procept Biorobotics Corporation  5.57 $ 180.972  Millions$ 32.504  Millions
Axonics Inc   5.40 $ 357.062  Millions$ 66.170  Millions
Cutera Inc   5.31 $ 267.651  Millions$ 50.379  Millions
Microbot Medical Inc   5.28 $ 5.106  Millions$ 0.967  Millions
Clearpoint Neuro Inc   5.24 $ 31.735  Millions$ 6.054  Millions
Asensus Surgical Inc   5.19 $ 56.434  Millions$ 10.877  Millions
Perspective Therapeutics Inc   5.07 $ 36.452  Millions$ 7.194  Millions
Bluejay Diagnostics Inc  4.78 $ 6.782  Millions$ 1.420  Millions
Nexalin Technology Inc   4.75 $ 5.473  Millions$ 1.152  Millions
Staar Surgical Co  4.33 $ 203.847  Millions$ 47.063  Millions
Tandem Diabetes Care Inc   4.24 $ 519.588  Millions$ 122.522  Millions
Profound Medical Corp   4.12 $ 26.213  Millions$ 6.366  Millions
Acutus Medical Inc   4.07 $ 69.577  Millions$ 17.110  Millions

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.